Elagolix/estradiol/norethindrone Interactions
There are 655 drugs known to interact with elagolix/estradiol/norethindrone, along with 26 disease interactions, and 9 alcohol/food interactions. Of the total drug interactions, 116 are major, 506 are moderate, and 33 are minor.
- View all 655 medications that may interact with elagolix/estradiol/norethindrone
- View elagolix/estradiol/norethindrone alcohol/food interactions (9)
- View elagolix/estradiol/norethindrone disease interactions (26)
Most frequently checked interactions
View interaction reports for elagolix / estradiol / norethindrone and the medicines listed below.
Elagolix/estradiol/norethindrone alcohol/food interactions
There are 9 alcohol/food interactions with elagolix / estradiol / norethindrone.
Elagolix/estradiol/norethindrone disease interactions
There are 26 disease interactions with elagolix / estradiol / norethindrone which include:
- abnormal genital bleeding
- hepatic impairment
- osteoporosis
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- depression/anxiety
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
Report options
QR code containing a link to this page
More about elagolix / estradiol / norethindrone
- elagolix/estradiol/norethindrone consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: sex hormone combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
